未找到相关数据
An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers
被引：68
作者：
Hollebecque, Antoine
Meyer, Tim
Moore, Kathleen N.
Machiels, Jean-Pascal H.
De Greve, Jacques
Lopez-Picazo, Jose Maria
Oaknin, Ana
Kerger, Joseph N.
Boni, Valentina
Evans, T. R. Jeffry
Kristeleit, Rebecca Sophie
Rao, Shangbang
Soumaoro, Ibrahima
Cao, Z. Alexander
Topalian, Suzanne Louise
机构：
[1] Gustave Roussy Canc Inst, Villejuif, France
[2] UCL, Canc Inst, London, England
[3] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[4] Clin Univ St Luc, Brussels, Belgium
[5] Vrije Univ Brussel, Brussels, Belgium
[6] Univ Navarra Clin, Pamplona, Spain
[7] Vall Hebron Univ Hosp Inst Oncol VHIO, Barcelona, Spain
[8] Inst Jules Bordet, Brussels, Belgium
[9] CIOCC Hosp Univ HM Sanchinarro, START Madrid, Madrid, Spain
[10] Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[11] Bristol Myers Squibb, Princeton, NJ USA
[12] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[13] Bloomberg Kimmel Inst Canc Immunotherapy Johns Ho, Baltimore, MD USA
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.5504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5504
引用
收藏
页数：6
相关论文